Analysis of messy longitudinal data from a randomized clinical trial. MRC Lung Cancer Working Party.

Abstract:

:The randomized clinical trial, LU19, conducted by the Medical Research Council Lung Cancer Working Party, was designed to compare ACE (doxorubicin, cyclophosphamide and etoposide) chemotherapy plus G-CSF (granulocyte colony-stimulating factor) at 2-week intervals versus ACE chemotherapy alone at standard 3-week intervals in patients with small-cell lung cancer. This trial investigated whether more intensive administration of ACE would improve overall survival and affect the quality of life of patients. The report on overall survival and other outcome measures will be published in the Journal of Clinical Oncology. In this paper we focus on methods of analysing aspects of data reflecting quality of life. Twelve symptoms of lung cancer and its treatment - cough, haemoptysis, pain, nausea, vomiting, hoarse voice, sore mouth, rash, lethargy, lack of appetite, alopecia, and dysphagia - were scheduled to be assessed on seven occasions for the ACE arm and on eight occasions for the ACE+G-CSF arm by clinicians during the first 18 weeks of the treatment period. However, in practice the number of assessment forms completed per patient ranged from 1 to 9, and assessment time-points were very different from those planned. These 'messy' longitudinal data are explored by both a summary measure approach, in which experience of a symptom is summarized by a single value, and an extensive model-based statistical approach, which explicitly takes into account correlation within repeated measures. These analyses provide a clear picture of symptom comparisons between the two treatments. The application of various methods offers not only an approach to assessing the robustness of the results but also a basis for investigating reasons for inconsistency of results across methods. We conclude that except lethargy, which is worse in the ACE+G-CSF arm, all symptoms are similar across the two arms during the treatment period.

journal_name

Stat Med

journal_title

Statistics in medicine

authors

Qian W,Parmar MK,Sambrook RJ,Fayers PM,Girling DJ,Stephens RJ

doi

10.1002/1097-0258(20001015)19:19<2657::aid-sim557>

subject

Has Abstract

pub_date

2000-10-15 00:00:00

pages

2657-74

issue

19

eissn

0277-6715

issn

1097-0258

pii

10.1002/1097-0258(20001015)19:19<2657::AID-SIM557>

journal_volume

19

pub_type

临床试验,杂志文章
  • A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring.

    abstract::In many chronic disease processes subjects are at risk of two or more types of events. We describe a bivariate mixed Poisson model in which a copula function is used to model the association between two gamma distributed random effects. The resulting model is a bivariate negative binomial process in which each type of...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3830

    authors: Cook RJ,Lawless JF,Lee KA

    更新日期:2010-03-15 00:00:00

  • An adjustment for a post-randomization variable in the comparison of two treatments for survival.

    abstract::A method is proposed to infer the randomized treatment effect on survival after an adjustment for a post-randomization variable. The post-randomization variable is made independent of the treatment assignment and is considered a surrogate for baseline prognostic factors. The relationship between the post-randomization...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.968

    authors: Heller G

    更新日期:2001-11-30 00:00:00

  • Flexible longitudinal linear mixed models for multiple censored responses data.

    abstract::In biomedical studies and clinical trials, repeated measures are often subject to some upper and/or lower limits of detection. Hence, the responses are either left or right censored. A complication arises when more than one series of responses is repeatedly collected on each subject at irregular intervals over a perio...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8017

    authors: Lachos VH,A Matos L,Castro LM,Chen MH

    更新日期:2019-03-15 00:00:00

  • Estimating time-dependent ROC curves using data under prevalent sampling.

    abstract::Prevalent sampling is frequently a convenient and economical sampling technique for the collection of time-to-event data and thus is commonly used in studies of the natural history of a disease. However, it is biased by design because it tends to recruit individuals with longer survival times. This paper considers est...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7184

    authors: Li S

    更新日期:2017-04-15 00:00:00

  • Design evaluation and optimisation in crossover pharmacokinetic studies analysed by nonlinear mixed effects models.

    abstract::Bioequivalence or interaction trials are commonly studied in crossover design and can be analysed by nonlinear mixed effects models as an alternative to noncompartmental approach. We propose an extension of the population Fisher information matrix in nonlinear mixed effects models to design crossover pharmacokinetic t...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4390

    authors: Nguyen TT,Bazzoli C,Mentré F

    更新日期:2012-05-20 00:00:00

  • Marker values at the time of an AIDS diagnosis.

    abstract::In this paper statistical methods are proposed to estimate the distribution of a CD4 T-cell number at the time of a clinical AIDS endpoint from serial measurements of CD4 T-cell values in a cohort study. The statistical formulation of the problem is that of survival analysis with interval censored data, but in which t...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780131915

    authors: Taylor JM,Kim DK

    更新日期:1994-10-15 00:00:00

  • Viral load detectability profiles for HIV infection.

    abstract::The introduction of potent antiretroviral therapies for treatment of HIV infection typically results in a dramatic reduction in plasma HIV RNA concentration, often to levels undetectable by current measurement practices. However, although a high proportion of patients achieve 'undetectability', many then experience a ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1325

    authors: McKinnon EJ,James IR,John M,Mallal SA

    更新日期:2003-02-15 00:00:00

  • Decomposition of number of life years lost according to causes of death.

    abstract::We study the competing risks model and show that the cause j cumulative incidence function integrated from 0 to τ has a natural interpretation as the expected number of life years lost due to cause j before time τ. This is analogous to the τ-restricted mean lifetime, which is the survival function integrated from 0 to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5903

    authors: Andersen PK

    更新日期:2013-12-30 00:00:00

  • Exact test size and power of a Gaussian error linear model for an internal pilot study.

    abstract::Wittes and Brittain recommended using an 'internal pilot study' to adjust sample size. The approach involves five steps in testing a general linear hypothesis for a general linear univariate model, with Gaussian errors. First, specify the design, hypothesis, desired test size, power, a smallest 'clinically meaningful'...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0258(19990530)18:10<1199::aid-s

    authors: Coffey CS,Muller KE

    更新日期:1999-05-30 00:00:00

  • Modification of the sample size and the schedule of interim analyses in survival trials based on data inspections.

    abstract::A method is presented which allows us to adapt the sample size as well as the number and time points of interim analyses to the treatment difference observed at an interim look during the course of a clinical trial with censored survival time as the endpoint. The method allows the inclusion of data inspections during ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.1136

    authors: Schäfer H,Müller HH

    更新日期:2001-12-30 00:00:00

  • Biomarker discovery using targeted maximum-likelihood estimation: application to the treatment of antiretroviral-resistant HIV infection.

    abstract::Researchers in clinical science and bioinformatics frequently aim to learn which of a set of candidate biomarkers is important in determining a given outcome, and to rank the contributions of the candidates accordingly. This article introduces a new approach to research questions of this type, based on targeted maximu...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3414

    authors: Bembom O,Petersen ML,Rhee SY,Fessel WJ,Sinisi SE,Shafer RW,van der Laan MJ

    更新日期:2009-01-15 00:00:00

  • Methods for comparing cumulative hazard functions in a semi-proportional hazard model.

    abstract::Graphical methods based on the analysis of differences between log cumulative hazard functions are considered for a two-group semi-proportional hazard model which allows for interaction between treatments and covariates. Confidence procedures and test statistics that can be used to test for interaction and for main ef...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780111105

    authors: Dabrowska DM,Doksum KA,Feduska NJ,Husing R,Neville P

    更新日期:1992-08-01 00:00:00

  • Predictive accuracy of risk factors and markers: a simulation study of the effect of novel markers on different performance measures for logistic regression models.

    abstract::The change in c-statistic is frequently used to summarize the change in predictive accuracy when a novel risk factor is added to an existing logistic regression model. We explored the relationship between the absolute change in the c-statistic, Brier score, generalized R(2) , and the discrimination slope when a risk f...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5598

    authors: Austin PC,Steyerberg EW

    更新日期:2013-02-20 00:00:00

  • Adaptive dose modification for phase I clinical trials.

    abstract::Most phase I dose-finding methods in oncology aim to find the maximum-tolerated dose from a set of prespecified doses. However, in practice, because of a lack of understanding of the true dose-toxicity relationship, it is likely that none of these prespecified doses are equal or reasonably close to the true maximum-to...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.6933

    authors: Chu Y,Pan H,Yuan Y

    更新日期:2016-09-10 00:00:00

  • Deficiencies in clinical reports for registration of drugs.

    abstract::A considerable number of the clinical reports which are presented to the Dutch Board for the Evaluation of Drugs, have deficiencies and/or shortcomings. A number of these, including loose description of the target population and sampling method, methodological flaws, incorrect treatment of withdrawals, confounding of ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780020209

    authors: De Jonge H

    更新日期:1983-04-01 00:00:00

  • Individualizing drug dosage with longitudinal data.

    abstract::We propose a two-step procedure to personalize drug dosage over time under the framework of a log-linear mixed-effect model. We model patients' heterogeneity using subject-specific random effects, which are treated as the realizations of an unspecified stochastic process. We extend the conditional quadratic inference ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.7016

    authors: Zhu X,Qu A

    更新日期:2016-10-30 00:00:00

  • Probabilistic cause-of-disease assignment using case-control diagnostic tests: A latent variable regression approach.

    abstract::Optimal prevention and treatment strategies for a disease of multiple causes, such as pneumonia, must be informed by the population distribution of causes among cases, or cause-specific case fractions (CSCFs). CSCFs may further depend on additional explanatory variables. Existing methodological literature in disease e...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.8804

    authors: Wu Z,Chen I

    更新日期:2021-02-20 00:00:00

  • A framework establishing clear decision criteria for the assessment of drug efficacy.

    abstract::Much has been published on various aspects of data analysis and reporting from clinical trials within the biopharmaceutical environment. This ranges from regulatory guidelines on the format and content of registration dossiers to recommendations on data presentation and the statistical methodologies that are appropria...

    journal_title:Statistics in medicine

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0258(19980815/30)17:15/16<1829:

    authors: Huster WJ,Enas GG

    更新日期:1998-08-15 00:00:00

  • On identifying a positive dose-response surface for combination agents.

    abstract::This article concerns construction of a confidence surface for tangential slopes of the dose-response surface of a combination therapy to identify where response increases as a function of drug dosage. This approach extends to the assessment of the effectiveness of the combination therapy. ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780110513

    authors: Hung HM

    更新日期:1992-03-01 00:00:00

  • Planning future studies based on the conditional power of a meta-analysis.

    abstract::Systematic reviews often provide recommendations for further research. When meta-analyses are inconclusive, such recommendations typically argue for further studies to be conducted. However, the nature and amount of future research should depend on the nature and amount of the existing research. We propose a method ba...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5524

    authors: Roloff V,Higgins JP,Sutton AJ

    更新日期:2013-01-15 00:00:00

  • Nonparametric sequential evaluation of diagnostic biomarkers.

    abstract::We consider evaluation and comparison of the diagnostic accuracy of biomarkers with continuous test outcomes, possibly correlated due to repeated measurements. We develop nonparametric group sequential testing procedures to evaluate and compare the area of biomarkers under their receiver operating characteristic curve...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3203

    authors: Liu A,Wu C,Schisterman EF

    更新日期:2008-05-10 00:00:00

  • A measure of similarity for response curves based on ranks.

    abstract::A measure of similarity for response curves is presented and its potential use is discussed. The distribution of a suitable test statistic for testing the independence of the course of two curves is derived. The method proposed is compared with other proposals in the literature for the analysis of paired response curv...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780081112

    authors: Schulgen G

    更新日期:1989-11-01 00:00:00

  • Infant growth modelling using a shape invariant model with random effects.

    abstract::Models for infant growth have usually been based on parametric forms, commonly an exponential or similar model, which have been shown to fit poorly especially during the first year of life. An alternative approach is to use a non-parametric model, based on a shape invariant model (SIM), where a single function is tran...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2718

    authors: Beath KJ

    更新日期:2007-05-30 00:00:00

  • Analysis of cluster randomized cross-over trial data: a comparison of methods.

    abstract::In a cluster randomized cross-over trial, all participating clusters receive both intervention and control treatments consecutively, in separate time periods. Patients recruited by each cluster within the same time period receive the same intervention, and randomization determines order of treatment within a cluster. ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.2537

    authors: Turner RM,White IR,Croudace T,PIP Study Group.

    更新日期:2007-01-30 00:00:00

  • A pathway analysis method for genome-wide association studies.

    abstract::For genome-wide association studies, we propose a new method for identifying significant biological pathways. In this approach, we aggregate data across single-nucleotide polymorphisms to obtain summary measures at the gene level. We then use a hierarchical Bayesian model, which takes the gene-level summary measures a...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4477

    authors: Shahbaba B,Shachaf CM,Yu Z

    更新日期:2012-05-10 00:00:00

  • Descriptive statistical analyses of serial dilution data.

    abstract::The serial dilution assay (for example, an in vitro antimicrobic susceptibility test or a serum antibody titer assay) is an important technique in biomedical research. The structure of the experiment forces grouping of the threshold concentrations into intervals. Statistical methods to analyse threshold concentrations...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.4780070410

    authors: Hamilton MA,Rinaldi MG

    更新日期:1988-04-01 00:00:00

  • Use of a density equalizing map projection in analysing childhood cancer in four California counties.

    abstract::In this study, 401 cases of childhood cancer in four California counties in 1980-1988 were analysed with the innovative methodology of density equalizing map projections. The data were originally collected and analysed by the California State Department of Health Services (DHS). In addition to the new analytic techniq...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.686

    authors: Merrill DW

    更新日期:2001-05-15 00:00:00

  • Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.

    abstract::Biological drug products are therapeutic moieties manufactured by a living system or organisms. These are important life-saving drug products for patients with unmet medical needs. Because of expensive cost, only a few patients have access to life-saving biological products. Most of the early biological products will ...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.5565

    authors: Lin JR,Chow SC,Chang CH,Lin YC,Liu JP

    更新日期:2013-02-10 00:00:00

  • Robust fitting for neuroreceptor mapping.

    abstract::Among many other uses, positron emission tomography (PET) can be used in studies to estimate the density of a neuroreceptor at each location throughout the brain by measuring the concentration of a radiotracer over time and modeling its kinetics. There are a variety of kinetic models in common usage and these typicall...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3510

    authors: Chang C,Ogden RT

    更新日期:2009-03-15 00:00:00

  • Establishing the relationship between nurse staffing and hospital mortality using a clustered discrete-time logistic model.

    abstract::Studies based on aggregated hospital outcome data have established that there is a relationship between nurse staffing and adverse events. However, this result could not be confirmed in Belgium where 96 per cent of the variability of nurse staffing levels over nursing units (belonging to different hospitals) is explai...

    journal_title:Statistics in medicine

    pub_type: 杂志文章

    doi:10.1002/sim.3756

    authors: Diya L,Lesaffre E,Van den Heede K,Sermeus W,Vleugels A

    更新日期:2010-03-30 00:00:00